Evolution of IL-6 as possible marker of viral control in Covid-19
C. De Diego Ramos (Zaragoza, Spain), L. López (Zaragoza, Spain), L. Torralba (Zaragoza, Spain), A. Lasierra (Huesca, Spain), R. Lahoz (Zaragoza, Spain), C. Abadía (Zaragoza, Spain), P. Ruiz De Gopegui (Zaragoza, Spain), A. Cebollada (Zaragoza, Spain), J. Godino (Zaragoza, Spain), B. Jimeno (Zaragoza, Spain), S. Bello (Zaragoza, Spain)
Source: International Congress 2022 – Biomarkers in COVID
Session: Biomarkers in COVID
Session type: Thematic Poster
Number: 348
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. De Diego Ramos (Zaragoza, Spain), L. López (Zaragoza, Spain), L. Torralba (Zaragoza, Spain), A. Lasierra (Huesca, Spain), R. Lahoz (Zaragoza, Spain), C. Abadía (Zaragoza, Spain), P. Ruiz De Gopegui (Zaragoza, Spain), A. Cebollada (Zaragoza, Spain), J. Godino (Zaragoza, Spain), B. Jimeno (Zaragoza, Spain), S. Bello (Zaragoza, Spain). Evolution of IL-6 as possible marker of viral control in Covid-19. 348
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|